Smartleaf Asset Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
Other funds holding TERN
Smartleaf Asset Management's TERN Position: Q2 2026 in Review
Smartleaf Asset Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 206 shares — an estimated $10.9K sold.
Smartleaf Asset Management first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $10.9K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.
- Smartleaf Asset Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Smartleaf Asset Management sold 206 Terns Pharmaceuticals shares in Q2 2026, an estimated $10.9K.
- Smartleaf Asset Management first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
- Smartleaf Asset Management's Terns Pharmaceuticals position peaked at $10.9K in Q1 2026.
- 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.
Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.